Cargando…

Donor Rejection Before Living Donor Liver Transplantation: Causes and Cost Effective Analysis in an Egyptian Transplant Center.

BACKGROUND: In the living donor liver transplant setting, the preoperative assessment of potential donors is important to ensure the donor safety. OBJECTIVES: The aim of this study was to identify causes and costs of living liver-donors rejection in the donation process. MATERIALS AND METHODS: From...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Meteini, Mahmoud, Dabbous, Hany, Sakr, Mohammad, Ibrahim, Amany, Fawzy, Iman, Bahaa, Mohamed, Abdelaal, Amr, Fathy, Mohamed, Said, Hany, Rady, Mohamed, El-Dorry, Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909637/ https://www.ncbi.nlm.nih.gov/pubmed/24497879 http://dx.doi.org/10.5812/hepatmon.13703

Ejemplares similares

Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt
por: Shaker, Mohammad Kamal, et al.
Publicado: (2018)

Bacterial infections post-living-donor liver transplantation in Egyptian hepatitis C virus-cirrhotic patients: A single-center study
por: Montasser, Mohamed F, et al.
Publicado: (2017)

Impact of biliary complications on quality of life in live-donor liver transplant recipients
por: Guirguis, Reginia Nabil, et al.
Publicado: (2021)

Biliary complications in recipients of living donor liver transplantation: A single-centre study
por: Guirguis, Reginia Nabil, et al.
Publicado: (2021)

Intensive care unit readmission in adult Egyptian patients undergoing living donor liver transplant: A single-centre retrospective cohort study
por: Salah, Manar, et al.
Publicado: (2022)

Egyptian protocol for living donor liver transplantation (LDLT) during SARS-CoV-2 pandemic
por: Abd Elbaset, Hany Said, et al.
Publicado: (2021)

Safety, Efficacy, and Tolerability of Sofosbuvir and Ribavirin in Management of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplant in Egypt: What Have We Learned so far?
por: Dabbous, Hany M., et al.
Publicado: (2016)

Repeated COVID-19 infection in recipients of post-living donor liver transplantation: Two real-life cases
por: Montasser, I.F., et al.
Publicado: (2021)

Risk factors and management of biliary stones after living donor liver transplant and its effect on graft outcome
por: Dabbous, Hany, et al.
Publicado: (2022)

The validity of central venous to arterial carbon dioxide difference to predict adequate fluid management during living donor liver transplantation. A prospective observational study
por: ELAyashy, Mohamed, et al.
Publicado: (2019)

Effects of bacterial translocation on hemodynamic and coagulation parameters during living-donor liver transplant
por: Moharem, Heba A., et al.
Publicado: (2018)

Analysis of Donor Motivations in Living Donor Liver Transplantation
por: Abdeldayem, Hesham, et al.
Publicado: (2014)

Corrigendum: Analysis of donor motivations in living donor liver transplantation
por: Abdeldayem, Hesham, et al.
Publicado: (2020)

Portal venous pressure and proper graft function in living donor liver transplants in 69 patients from an Egyptian center
por: Sholkamy, Amany, et al.
Publicado: (2018)

Can living donor liver transplantation provide similar outcomes to deceased-donor liver transplantation for hepatocellular carcinoma? A systematic review and meta-analysis
por: Elkomos, Beshoy Effat, et al.
Publicado: (2022)

CYP3A5 Gene-Guided Tacrolimus Treatment of Living-Donor Egyptian Kidney Transplanted Patients
por: Mendrinou, Effrosyni, et al.
Publicado: (2020)

Impact of pre-transplant infection management on the outcome of living-donor liver transplantation in Egypt
por: Saleh, Ahmed Mohamed, et al.
Publicado: (2019)

Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma
por: Omar, Ashraf, et al.
Publicado: (2023)

Outcome of COVID-19 in Egyptian living-donor kidney transplant recipients and relation to maintenance immunosuppressive drugs: a pilot study
por: ElNahid, Maggie Said, et al.
Publicado: (2023)

Study of Early Postoperative Doppler Changes Post Living Donor Liver Transplantation and Their Impact on Early Mortality and Small-for-Size Syndrome: A Retrospective Study
por: Salman, Ahmed, et al.
Publicado: (2021)

Approaching treatment for immunological rejection of living-donor liver transplantation in rats
por: Feng, Yanhu, et al.
Publicado: (2020)

Feasibility and outcomes of living-donor liver transplantation utilizing the right hemi-liver graft with portal vein anatomical variations
por: Shehta, Ahmed, et al.
Publicado: (2023)

Developing a mortality risk prediction model using data of 3663 hospitalized COVID-19 patients: a retrospective cohort study in an Egyptian University Hospital
por: Kandil, Sahar, et al.
Publicado: (2023)

Suppression of liver transplant rejection by anti-donor MHC antibodies via depletion of donor immunogenic dendritic cells
por: Ueta, Hisashi, et al.
Publicado: (2020)

The impact of vitamin D supplementation on peripheral neuropathy in a sample of Egyptian prediabetic individuals
por: Reda Halawa, Mohamed, et al.
Publicado: (2021)

Hepatic venous outflow obstruction after living donor liver transplantation managed with ectopic placement of a foley catheter: A case report
por: Wahab, Mohamed Abdel, et al.
Publicado: (2015)

Ligation of huge spontaneous porto-systemic collaterals to avoid portal inflow steal in adult living donor liver transplantation: A case-report
por: Elshobary, Mohamed, et al.
Publicado: (2017)

Characteristics of Donor-Specific Antibodies Associated With Antibody-Mediated Rejection in Lung Transplantation
por: Roux, Antoine, et al.
Publicado: (2017)

Albuminuria as a predictor of mortality in type II diabetic patients after living-donor liver transplantation
por: Salman, Ahmed Abdallah, et al.
Publicado: (2022)

Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation
por: Elmariah, Hany, et al.
Publicado: (2021)

Adrenalectomy for solitary recurrent hepatocellular carcinoma five years after living donor liver transplantation: A case report
por: Abdel Wahab, Mohamed, et al.
Publicado: (2018)

Anthropometric, biochemical and clinical assessment of malnutrition among Egyptian children with chronic liver diseases: a single institutional cross-sectional study
por: Koofy, Nehal El, et al.
Publicado: (2019)

Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients
por: Jordan, Stanley C., et al.
Publicado: (2018)

Combining donor-derived cell-free DNA and donor specific antibody testing as non-invasive biomarkers for rejection in kidney transplantation
por: Obrișcă, Bogdan, et al.
Publicado: (2022)

Renal Dysfunction after Living-Donor Liver Transplantation: Experience with 500 Cases
por: Abdel-Khalek, Ehab E., et al.
Publicado: (2018)

Biomaterials-enabled cornea regeneration in patients at high risk for rejection of donor tissue transplantation
por: Islam, M. Mirazul, et al.
Publicado: (2018)

Donor-Derived Cell-Free DNA for Acute Rejection Monitoring in Heart and Lung Transplantation
por: Keller, Michael, et al.
Publicado: (2021)

Role of biliary complications in chronic graft rejection after living donor liver transplantation
por: Obed, Aiman, et al.
Publicado: (2022)

Retraction Note to: Approaching treatment for immunological rejection of living-donor liver transplantation in rats
por: Feng, Yanhu, et al.
Publicado: (2022)

Polyfunctional donor-reactive T cells are associated with acute T-cell-mediated rejection of the kidney transplant
por: Litjens, Nicolle H R, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ni96mi4uka1v4o6tcb6b4kqusb